Maharashtra University of Health Science (MUHS) has recently released the Summer 2025 session results of various courses like ...
The MEDALIST trial was a phase 3 study with patients with ESA-refractory, low-risk MDS who require transfusions. In this ...
David Mitchell, PharmD, MBA, UC Davis, shares how collaboration between health systems and manufacturers is transforming patient access and outcomes for rare disease treatments.
Plus, a Texas Community health association awards Texas lawmaker and Trinity Hunt Partners announces new healthcare-focused ...
With the future of healthcare increasingly uncertain, more doctors are seeking MBAs, MPHs, and other degrees to expand their ...
How Health Systems, Pharmacy Teams Tackle Rare Disease Therapy Barriers: David Mitchell, PharmD, MBA
David Mitchell, PharmD, MBA, senior pharmacist manager and assistant clinical professor at UC Davis, addresses how health systems are overcoming financial, operational, and access challenges for ...
Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. M.B.A. programs have become critical for the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback